42 related articles for article (PubMed ID: 17628932)
1. Transrectal versus transperineal prostate biopsy for cancer detection in patients with gray-zone prostate-specific antigen: a multicenter, real-world study.
Liu JX; Wang ZY; Niu SX; Sai XY; Zhang X; Zhang XP; Ma X
Asian J Androl; 2024 Jul; 26(4):377-381. PubMed ID: 38624201
[TBL] [Abstract][Full Text] [Related]
2. TRUS Biopsy Yield in Indian Population: A Retrospective Analysis.
Patil SR; Pawar PW; Sawant AS; Patil AV; Narwade SS; Mundhe ST; Savalia AJ; Tamhankar AS
J Clin Diagn Res; 2017 Feb; 11(2):PC01-PC05. PubMed ID: 28384926
[TBL] [Abstract][Full Text] [Related]
3. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
[TBL] [Abstract][Full Text] [Related]
4. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
Yokomizo Y; Miyoshi Y; Nakaigawa N; Makiyama K; Ogawa T; Yao M; Kubota Y; Uemura H
Urol Int; 2009; 82(3):280-5. PubMed ID: 19440014
[TBL] [Abstract][Full Text] [Related]
5. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
6. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
7. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy.
Kawakami S; Okuno T; Yonese J; Igari T; Arai G; Fujii Y; Kageyama Y; Fukui I; Kihara K
Eur Urol; 2007 Mar; 51(3):675-82; discussion 682-3. PubMed ID: 16843585
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of transrectal needle biopsy of the prostate: usefulness of systematic 12 core biopsy].
Imazu T; Yokoyama S; Fukuhara S; Hara T; Yamaguchi S; Adachi S
Hinyokika Kiyo; 2007 Jun; 53(6):365-8. PubMed ID: 17628932
[TBL] [Abstract][Full Text] [Related]
9. [Biopsies of the transitional zone: impact on the detection of prostatic cancer and prognostic value].
Peyromaure M; Ravery V; Boccon-Gibod L
Prog Urol; 2002 Feb; 12(1):8-14. PubMed ID: 11980019
[TBL] [Abstract][Full Text] [Related]
10. [Prostate biopsy].
Suzuki K; Ito K
Nihon Rinsho; 2005 Feb; 63(2):253-9. PubMed ID: 15714975
[TBL] [Abstract][Full Text] [Related]
11. Improving cancer detection by prostate biopsy: the role of core number and site.
Shinohara K
Nat Clin Pract Urol; 2006 Oct; 3(10):526-7. PubMed ID: 17031375
[No Abstract] [Full Text] [Related]
12. Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancer.
Fine SW; Reuter VE
Histopathology; 2012 Jan; 60(1):142-52. PubMed ID: 22212083
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
